CHEMED CORP
Company Stats
- Market Cap
- $6.6B
- as of Sep 30, 2026
- Shares Outstanding
- 13.0M
- Free Float
- 95.5%
Income Statement
- Revenue
- $2.5B
- Operating Income
- $338.2M
- Net Income
- $265.2M
- EBITDA
- $403.1M
- Revenue Growth, 3Y
- 5.8%
- FCF Margin, 3Y Avg
- 13.4%
- FCF Margin, Worst Year
- 12.1%
Cash Flow
- Free Cash Flow
- $325.5M
- FCF Yield
- 4.9%
- Owner FCF Yield
- 4.3%
Balance Sheet
- Cash & Equivalents
- $74.5M
Returns & Capital
- Dividends Paid
- $31.7M
- Dividend Yield
- 0.5%
- Dividend Payout, 3Y Avg
- 9.8%
- Share Repurchases
- $431.5M
- Buyback Yield, 3Y Avg
- 4.3%
- SBC, 3Y Avg
- $43.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $2.5B | $325.5M | 12.9% |
| FY2024 | $2.4B | $368.0M | 15.1% |
| FY2023 | $2.3B | $273.4M | 12.1% |
| FY2022 | $2.1B | $252.6M | 11.8% |
| FY2021 | $2.1B | $249.9M | 11.7% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back